2022 New ACR Guidance on Glucocorticoid-Induced Osteoporosis (GIOP) The ACR has updated this guideline and includes rec
Tweet Content
2022 New ACR Guidance on Glucocorticoid-Induced Osteoporosis (GIOP)
The ACR has updated this guideline and includes recommendations on abaloparatide (PTHrP) and romosozumab, which are newly available since the ACR’s 2017 GIOP guideline.
https://t.co/byehJlihCY https://t.co/xnKPC1V0l7
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off